According to GlobalData’s medical device pipeline database, 27 Positron Emission Tomography (PET) Systems devices are in various stages of development globally. GlobalData’s report Positron Emission Tomography (PET) Systems provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 19 are in active development, while the remaining eight are in an inactive stage of development. There are 14 products in the early stages of development, and the remaining five are in the late stages of development.
A Positron Emission Tomography (PET) scan is an imaging test that helps reveal how your tissues and organs are functioning. A PET scan uses a radioactive drug (tracer) to show this activity. The tracer may be injected, swallowed or inhaled, depending on which organ or tissue is being studied by the PET scan. The tracer collects in areas of your body that have higher levels of chemical activity, which often correspond to areas of disease. On a PET scan, these areas show up as bright spots. A PET scan is useful in revealing or evaluating several conditions, including some cancers, heart disease and brain disorders. The device consists of a detector, gantry system, patients table and a transmission source. One unit refers to one positron emission tomography (PET) system.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Positron Emission Tomography (PET) Systems pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Positron Emission Tomography (PET) Systems devices. Overall, most of these Positron Emission Tomography (PET) Systems pipeline devices are being developed by private entities.
Key players involved in the active development of Positron Emission Tomography (PET) Systems include Stanford University, Stanford University, SynchroPET, Brain Biosciences, University of Washington, General De Equipment for Medical Imaging, Jagiellonian University, King's College London, MultiFunctional Imaging and Nalu Scientific.
For a complete picture of the developmental pipeline for Positron Emission Tomography (PET) Systems devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.